# Prelude Therapeutics Inc: Form 8-K, filed Jan 28, 2021

- Company: [Prelude Therapeutics Inc](/companies/prld.md) (CIK 1678660)
- Form: 8-K
- Filed: 2021-01-28
- Accepted by EDGAR: Jan 28, 2021, 16:46 ET
- Period: 2021-01-22
- Accession: 0001193125-21-020863
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1678660/000119312521020863/d116309d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1678660/000119312521020863/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1678660/000119312521020863/d116309d8k.htm

Filed Jan 28, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-020863. Last ingested by Listed: Oct 24, 2026, 15:15 ET. No prices; not investment advice.
